期刊文献+

吡格列酮配合生活干预对SHR大鼠降压及主动脉壁的保护作用 被引量:4

Pioglitazone combination with life style intervention on blood pressure and the protective effect of aorta in spontaneously hypertensive rats
下载PDF
导出
摘要 目的观察胰岛素增敏剂吡格列酮(PIO)配合生活干预对自发性高血压大鼠(SHR)的降压、降糖、调脂作用,以及对主动脉壁的保护作用。方法 SHR大鼠45只,随机分为4组:对照组,PIO组,生活干预组,PIO+生活干预组。药物添加到大鼠饮水中,生活干预为每日减少投食量并游泳6~15min,实验周期为12w。采用尾动脉血压间接测量法定期测血压,并采用生化分析仪测定血糖,血脂。采用光镜方法观察各组大鼠主动脉壁形态学变化情况。结果 PIO有良好的降压、降糖、调脂作用,PIO配合生活干预的降压、降糖、降脂效果更佳,血管保护作用最强。结论 PIO及配合生活干预具有良好的降低SHR大鼠血压及血管保护作用,生活干预可作为纠正IR的方法之一应用到高血压的治疗当中。 Objective To evaluate the effects of insulin sensilizer ( Pioglitazone PIO) combination with life style intervention on blood pressure and glucose and lipid in spontaneously hypertensive rats ( SHRs), analyze the protective effect of aorta. Methods Forty five SHRs were randomly assigned to SHR control, PIO,life style intervention and PIO combination with life style intervention groups, using re- ducing the rat food and swimming (6 ~ 15 min/d) as life style intervention for 12 w. Results PIO had satisfactory effects on blood pres- sure, glucose and lipid, PIO combine with life style intervention had better protective of aorta. Conclusions PlO combination with life style intervention have satisfactory effects on blood pressure and the aorta,life style intervention could be a good method as rectifying IR on depressurization.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2010年第13期1854-1856,共3页 Chinese Journal of Gerontology
基金 吉林省科技厅资助课题(200705165)
关键词 胰岛素抵抗 生活干预 主动脉壁 Insulin resistance Life style Aorta wall
  • 相关文献

参考文献10

  • 1杨连伟,孔俭,葛姝颖.罗格列酮对自发性高血压大鼠心脏保护作用的形态学研究[J].中国老年学杂志,2004,24(10):937-939. 被引量:6
  • 2He J,Klag MJ,Caballero B,et al.Plasma insulin level and incidence of hypertension in African Americans and whites[J].Arch Intern Med,1999,159(5):498-503.
  • 3Zavaroni I,Bonini L,Gasparini P,et al.Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus,hypertension,and coronary heart disease:the Barilla factory revisited[J].Metabolism,1999;48(8):989-94.
  • 4Laterza MC,de Matos LD,Trombetta IC,et al.Exercise training restores baroreflex sensitivity in never-treated hypertensive patients[J].Hypertension,2007;49(6):1298-306.
  • 5Guo Q,Minami N,Mori N,et al.Effects of antihypertensive drugs and exercise training on insulin sensitivity in spontaneously hypertensive rats[J].Hypertens Res,2008;31(13):525-33.
  • 6Asakawa M,Nagai T,Nagai T,et al.Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo[J].Circulation,2002;105(10):1240-6.
  • 7Mann JI.Can dietary intervention produce long-term reduction in insulin resistance[J] ?Br J Nutr,2000;83(1):169-72.
  • 8孔俭,姜宏宇,荣爱红.罗格列酮对高血压大鼠主动脉壁保护作用的形态学研究[J].中国老年学杂志,2005,25(4):416-418. 被引量:4
  • 9Schiffrin EL,Amiri F,Benkirane K,et al.Peroxisome proliferator-activated receptors:vascular and cardiac effects in hypertension[J].Hypertension,2003;42(4):664-8.
  • 10陈海燕,李杰,梁虹霞,孔俭,杨玉双.罗格列酮对SHR大鼠降压作用和靶器官保护机制研究[J].中国老年学杂志,2007,27(20):1970-1973. 被引量:3

二级参考文献22

  • 1何淑梅,汲宏磊,孔俭,葛姝颖.罗格列酮对自发性高血压大鼠肾脏保护作用的形态学研究[J].吉林大学学报(医学版),2005,31(4):571-573. 被引量:2
  • 2赵清.高血压性心肌纤维化及其调控机制[J].国外医学(心血管疾病分册),1996,23(2):69-72. 被引量:23
  • 3Reaven GM. Banting Lecture 1988.Role of insulin resistance in human disease[J]. Diabetes,1988;37(12):1595-607.
  • 4Diep ON, Cohn JS .Schiffrin EL. Structure,endothelial function ,cell growth and inflammation in blood vessels of angiotensin II -induced rats :role of peroxisome proliferator-activated receptor-gamma [J].Circulation,2002;105(19):2296-302.
  • 5WalkerAB. Chattington PD,William SG ,et al . The thiazolidinedione rosiglitazone(BRL -L9653) lowers the blood pressure and protects against impairment of endothelial function in Zuker fatty rats[J]. Diabetes,1999;48(7):1448-53.
  • 6Sidhu JS, Cowan D , Kaski JC,et al . The effects of rosiglitazone. A peroxisome proliferators-activated receptor -gamma agonist,on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non -diabetic coronary artery disease patients [J]. J Am Coll Cardiol,2003;42(10):1757-63.
  • 7Wang CH ,Stanford WL ,Verma S, et al .Facilitate angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in giltazone pleiotropy [J].Circulation,2004;109(11):1392-400.
  • 8Dilley RJ ,Jennings GL ,Law RE ,et al . Inhibitory activity of clinical thiazolidinedione peroxisome proliferators activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation [J].Circulation,2003;107(20):2548-50.
  • 9Weber AA, Seul C, Sachinidis A ,et al . Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth[J]. Exp Clin Endocrinol Diabetes,2001;109(4):203-9.
  • 10Law RE, Goetze S, Xipe T, et al . Ppar-gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells [J].J Cardiovasc Pharmacol,1999;33(5):798-806.

共引文献9

同被引文献42

  • 1宋铁山,李旭光,唐茂林.导入人内皮型一氧化氮合酶基因对高盐饮食大鼠的血压及肾脏功能的影响[J].中华高血压杂志,2007,15(4):303-306. 被引量:11
  • 2朱肖星,牛小麟,魏瑾,陈定章,朱萧玲,马晓涛,高登峰,郝广华,李高中,徐琳,王文清.罗格列酮对内皮素引起心肌细胞损伤的保护作用及机制[J].第四军医大学学报,2007,28(14):1317-1319. 被引量:4
  • 3Zemel MB.Insulin resistance vs.hyperinsulinemia in hypertension:insulin regulation of Ca2+ transport and Ca2+regulation of insulin sensitivity[J].J Nutr,1995;125(6):1738-43.
  • 4Guo X,Cheng S,Taylor KD,et al.Hypertension genes are genetic markers for insulin sensitivity and resistance[J].Hypertension,2005;45(4):799-803.
  • 5Chamiot-Clert P,Renaud JF,Safar ME.Pulse pressure,aortic reactivity,and endothelium dysfunction in old hypertensive rats[J].Hypertension,2001;37(2):313-21.
  • 6Mayet J,Hughes A.Cardiac and vascular pathophysiology in hypertension[J].Heart,2003;89(9):1104-9.
  • 7Chatterjee A,Black SM,Catravas JD.Endothelial nitric oxide(NO) and its pathophysiologic regulation[J].Vascul Pharmacol,2008;49(4-6):134-40.
  • 8Yetik-Anacak G,Catravas JD.Nitric oxide and the endothelium:history and impact on cardiovascular disease[J].Vascul Pharmacol,2006;5(45):268-76.
  • 9Cohen JD.Overview of physiology,vascular biology,and mechanisms of hypertension[J].J Manag Care Pharm,2007;13(5):6-8.
  • 10Hoffman JJ,Gilbert TB,Poston RS,et al.Myocardial reperfusion injury:etiology,mechanisms,and therapies[J].J Extra Corpor Technol,2004;36(4):391-411.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部